Source:http://linkedlifedata.com/resource/pubmed/id/19371956
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2009-6-1
|
pubmed:abstractText |
Spontaneous miscarriage and preterm delivery are common complications of pregnancy. Pro-inflammatory cytokines have been shown to be associated with recurrent spontaneous miscarriage (RSM) and preterm delivery (PTD) and these have led to exploration of ways to downregulate pro-inflammatory cytokines and/or to upregulate anti-inflammatory cytokines. Progesterone-induced blocking factor (PIBF) is a molecule with inhibitory effects on cell-mediated immune reactions. We have ascertained the effects of PIBF on secretion of selected type 1 and type 2 cytokines by peripheral blood mononuclear cells from healthy non-pregnant women, women undergoing normal pregnancy, women with unexplained RSM and women with PTD. Peripheral blood mononuclear cells from 30 women with a history of unexplained RSM, 18 women undergoing PTD, 11 women with normal pregnancy and 13 non-pregnant healthy women were stimulated with a mitogen in the absence and presence of PIBF after which the levels of cytokines released into culture supernatants were determined by ELISA. Production of the type 2 cytokines IL-4, IL-6 and IL-10 by lymphocytes from the RSM and PTD groups and of IL-4 and IL-10 by lymphocytes from healthy pregnant women was significantly increased upon exposure to PIBF, while the levels of type 1 cytokines were not affected. Ratios of type 1:type 2 cytokines were decreased, suggesting a shift towards Th2 bias. PIBF did not affect cytokine production by lymphocytes from non-pregnant women. Thus, PIBF acts on lymphocytes in pregnancy to induce a type 1 to type 2 cytokine shift by upregulating the production of type 2 cytokines.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1872-7603
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
91-9
|
pubmed:meshHeading |
pubmed-meshheading:19371956-Abortion, Habitual,
pubmed-meshheading:19371956-Cells, Cultured,
pubmed-meshheading:19371956-Cytokines,
pubmed-meshheading:19371956-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19371956-Female,
pubmed-meshheading:19371956-Humans,
pubmed-meshheading:19371956-Immune Tolerance,
pubmed-meshheading:19371956-Lymphocyte Activation,
pubmed-meshheading:19371956-Placenta,
pubmed-meshheading:19371956-Pregnancy,
pubmed-meshheading:19371956-Pregnancy Proteins,
pubmed-meshheading:19371956-Premature Birth,
pubmed-meshheading:19371956-Suppressor Factors, Immunologic,
pubmed-meshheading:19371956-Th1 Cells,
pubmed-meshheading:19371956-Th2 Cells
|
pubmed:year |
2009
|
pubmed:articleTitle |
Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery.
|
pubmed:affiliation |
Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait. raj@hsc.edu.kw
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|